Recent Security Class Actions

Sana Biotechnology Inc. Common Stock (NASDAQ: SANA)

48 Days left to seek lead plaintiff status.

Company Name:Sana Biotechnology Inc. Common Stock
Stock Symbol:NASDAQ: SANA
Class Period Start:03/17/2023
Class Period End (inclusive):11/04/2024
Filing Deadline:05/20/2025

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding Sana's business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Sana was at significant risk of having insufficient funds to maintain its current operations and advance one or more of its product candidates; (ii) SC291 in oncology, SC379, and SG299 were less promising than Defendants had led investors to believe; (iii) in order to preserve cash and advance its more promising product candidates, Sana was likely to decrease funding for and/or discontinue SC291 in oncology, SC379, and SG299, as well as significantly reduce its headcount; (iv) accordingly, Defendants overstated Sana's financial capacity to maintain its current operations and advance its existing product candidates; and (v) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Sana Biotechnology Inc. Common Stock (NASDAQ: SANA) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.